To test whether GSK-3β inhibition could attenuate liver injury during sepsis via inhibition of inflammation, the production of TNF-α, IL-6, IL-1β, and IL-10 was analyzed at 6 h following CLP. This evidence concerns the gene IL1B and Sepsis.